AbCellera Partners with Vertex to Develop Multispecific T-Cell Engagers
VANCOUVER, British Columbia, July 29, 2026 AbCellera Biologics Inc. announced a strategic collaboration with Vertex Pharmaceuticals to research, develop,...
T-Cell Engagers
Advertisement
Voro and Alloy Partner on Next-Gen T-Cell Cancer Therapies
SAN DIEGO, Calif. and BOSTON, Mass., June 20, 2026 Voro Therapeutics and Alloy Therapeutics have announced a strategic research...
Jazz and AbCellera Partner on Next-Gen Cancer Antibodies
DUBLIN, Ireland and VANCOUVER, British Columbia, June 17, 2026 Jazz Pharmaceuticals and AbCellera have announced a major strategic collaboration...
DISCO–Amgen License Deal Advances Surfaceome Cancer Therapies
COLOGNE, Germany – January 7, 2026 — DISCO Pharmaceuticals has entered into an exclusive global license agreement with Amgen...
Advertisement
